Dr. Magliocco to Present at Future Genomics 2023
Dr. Magliocco will be presenting a special lecture at Future Genomics 2023 on the roles of genomic testing technology for improving the diagnosis and treatment of cancer patients.
Topics will include:
Implementing WES as part of the Protean MAPS™ precision oncology system
Clinical uses of multiplex IHC for analysis of PDL1 in cancer specimens
How the Protean MAPS™ system delivers fully integrated multiomics data for cancer patients
Dr. Magliocco is the Founder and CEO of Protean BioDiagnostics, the home of Protean MAPS™ the most innovative precision cancer diagnostic platform available, focused on improving outcomes in cancer patients using integrated diagnostics, pathology, genomics, molecular diagnostics, AI and telemedicine.
Meeting Details
Dates:
Match 22-23, 2023
Location:
Kimpton Marlow Hotel
Cambridge, Massachusetts
For further information, please contact:
Anthony Magliocco MD
CEO & President of Protean BioDiagnostics
Email: info@proteanbiodx.com
Phone: 1 (813) 817 2042
About Protean BioDiagnostics
Protean BioDiagnostics is revolutionizing modern healthcare with our Protean MAPS™ system, which integrates health screening, diagnostics, treatment guidance, and tele-medicine backed decision support.
We collaborate with physicians and health groups to support them in providing the best possible care for their patients, regardless of where they live.